Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Ventyx Biosciences Inc (VTYX)

Ventyx Biosciences Inc (VTYX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences GlobeNewswire - Tue Nov 12, 6:30AM CST

VTYX : 1.7300 (+0.58%)
Ventyx Biosciences Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate Progress GlobeNewswire - Thu Nov 7, 3:05PM CST

VTYX : 1.7300 (+0.58%)
Ventyx Biosciences Presents New 52-Week Results from the Phase 2 Trial of VTX002 (Tamuzimod) in Ulcerative Colitis at UEG Week 2024 GlobeNewswire - Tue Oct 15, 7:00AM CDT

VTYX : 1.7300 (+0.58%)
Why Shares of Ventyx Biosciences Are Dropping Tuesday Motley Fool - Tue Oct 10, 2023

Investors were unimpressed by the company's trial results for an ulcerative colitis therapy.

PFE : 25.13 (+0.76%)
VTYX : 1.7300 (+0.58%)
Why Shares of Ventyx Biosciences Rose Monday Motley Fool - Mon Jul 3, 2023

The company has several promising autoimmune therapies.

DICE : 47.55 (+0.06%)
RXDX : 199.92 (+0.09%)
MRK : 99.86 (+2.48%)
LLY : 749.92 (-0.46%)
VTYX : 1.7300 (+0.58%)
Why Ventyx Biosciences Zoomed Nearly 60% Higher This Week Motley Fool - Fri Sep 16, 2022

The biotech benefits from a much larger peer's recent FDA approval.

VTYX : 1.7300 (+0.58%)
Ventyx Biosciences Announces Positive Topline Phase 1 Data for its Peripheral NLRP3 Inhibitor VTX2735 Globe Newswire - Wed Jun 29, 2022

Excellent safety, tolerability and pharmacokinetic profile Robust dose-dependent target engagement as measured by ex vivo IL-1β release assay Phase 2...

VTYX : 1.7300 (+0.58%)
Ventyx Biosciences to Participate in the Jefferies Healthcare Conference Globe Newswire - Wed Jun 1, 2022

ENCINITAS, Calif., June 01, 2022 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX), (“Ventyx”), a clinical-stage biopharmaceutical company...

VTYX : 1.7300 (+0.58%)
Ventyx Biosciences Reports First Quarter 2022 Financial Results and Highlights Recent Corporate Progress Globe Newswire - Thu May 12, 2022

Topline Phase 1 data for our allosteric TYK2 inhibitor, VTX958, expected in early Q3 2022 Topline Phase 1 data for our selective NLRP3 inhibitor, VTX2735,...

VTYX : 1.7300 (+0.58%)
Ventyx Biosciences to Report First Quarter 2022 Financial Results on May 12, 2022 Globe Newswire - Thu May 5, 2022

ENCINITAS, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX), (“Ventyx”), a clinical-stage biopharmaceutical company...

VTYX : 1.7300 (+0.58%)

Barchart Exclusives

Recent Corn Rally Artificially Propped Up – What’s Next? Barchart - 41 minutes ago
Corn prices appeared to have finally found a bottom from the summer sell-off. Speculators were short the market in record numbers until late August, when they began buying back contracts, convincing some that the harvest seasonal low may be in. Then, exports increased in the last few weeks, and prices rallied more. While the bearish fundamentals of 1.9 billion carry-out and the massive amount of unpriced corn still linger, there isn’t much hope for a significant price rally yet. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot